(Q37780348)

23 August 2017

1 reference

title

The need for quadrivalent vaccine against seasonal influenza (English)

1 reference

23 August 2017

1 reference

1

Robert B Belshe

1 reference

PubMed ID

20713260

23 August 2017

language of work or name

English

0 references

publication date

1 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

28 Suppl 4

1 reference

23 August 2017

D45-53

1 reference

Multiple genotypes of influenza B virus circulated between 1979 and 2003.

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Clinical and genetic characterization of severe influenza B-associated diseases during an outbreak in Taiwan.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Comparison of the mutation rates of human influenza A and B viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Influenza A and B virus infections in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Lessons learned: role of influenza vaccine production, distribution, supply, and demand--what it means for the provider

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Vaccine supply problems: a perspective of the Centers for Disease Control and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

Emerging vaccines for influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.08.028

10.1016/J.VACCINE.2010.08.028

7 January 2021

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20713260